Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis

World Journal of Gastroenterology

Volumn 13, Issue 24, 2007, Pages 3359-3363

  Mohamadnejad, Mehdi ^a,b   Namiri, Mehrnaz ^c   Bagheri, Mohamad ^a   Hashemi, Seyed Masiha ^c   Ghanaati, Hossein ^a   Mehrjardi, Narges Zare ^c   Ashtiani, Saeed Kazemi ^a   Malekzadeh, Reza ^a   Baharvand, Hossein ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

Bone marrow; Cirrhosis; Model of End Stage Liver Disease score; Quality of life; Stem cell; Transplantation

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; NONIONIC CONTRAST MEDIUM;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; CD34 SELECTION; CELL ISOLATION; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATIC ARTERY; HEPATORENAL SYNDROME; HUMAN; KIDNEY DISEASE; LIVER CIRRHOSIS; MALE; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PROTHROMBIN TIME; QUALITY OF LIFE; SCORING SYSTEM;

EID: 34447318595     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i24.3359     Document Type: Article

References (21)

1. Ganji A, Safavi M, Nouraie SM, Nasseri-Moghadam S, Merat Sh, Vahedi H, Malekzadeh R. Digestive and liver diseases statistics in several referral centers in Tehran, 2000-2004. Govaresh 2006; 11:33-38
2. Malek-Hosseini SA, Mehdizadeh AR, Salahi H, Saberi-Firouzi M, Bagheri-Lankarani K, Bahador A, Imanieh MH, Nik-Eghbalian S, Lahsaee M, Khosravi MB, Arasteh MM, Bagheri MH, Geramizadeh B, Razmkon A, Tabei SZ. Results of liver transplantation: analysis of 140 cases at a single center. Transplant Proc 2005; 37:3157-3158
3. Sakaida I, Terai S, Nishina H, Okita K. Development of cell therapy using autologous bone marrow cells for liver cirrhosis. Med Mol Morphol 2005; 38:197-202
4. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355:1210-1221
5. Almeida-Porada G, Porada CD, Chamberlain J, Torabi A, Zanjani ED. Formation of human hepatocytes by human hematopoietic stem cells in sheep. Blood 2004; 104:2582-2590
6. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K. Transplantation of bone marrow cells reduces CC14-induced liver fibrosis in mice. Hepatology 2004; 40:1304-1311
7. + bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005; 23: 463-470
8. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005; 14:875-882
9. Mohyeddin Bonab M, Yazdanbakhsh S, Alimoghaddam K, Talebian F, Hooshmand F, Lotfi J, Ghavamzadeh A. Mesenchymal stem cell therapy for multiple sclerosis. Int J Hematol Oncol BMT 2005; 2:10-16
10. Snyder EY, Daley GQ, Goodell M. Taking stock and planning for the next decade: realistic prospects for stem cell therapies for the nervous system. J Neurosci Res 2004; 76:157-168
11. Gaia S, Smedile A, Omede P, Olivero A, Sanavio F, Balzola F, Ottobrelli A, Abate ML, Marzano A, Rizzetto M, Tarella C. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006; 45:13-19
12. + stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006; 24: 1822-1830
13. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. AJR Am J Roentgenol 1991; 157:59-65
14. Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S, Gopalan R. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992; 182:649-655
15. Back MR, Caridi JG, Hawkins IF Jr, Seeger JM. Angiography with carbon dioxide (CO2). Surg Clin North Am 1998; 78: 575-591
16. Gasbarrini A, Rapaccini GL, Rutella S, Zocco MA, Tittoto P, Leone G, Pola P, Gasbarrini G, Di Campli C. Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis 2006; Epub ahead of print
17. Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006; 43:2-8
18. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422:897-901
19. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004; 6:532-539
20. Burns TC, Ortiz-Gonzalez XR, Gutierrez-Perez M, Keene CD, Sharda R, Demorest ZL, Jiang Y, Nelson-Holte M, Soriano M, Nakagawa Y, Luquin MR, Garcia-Verdugo JM, Prosper F, Low WC, Verfaillie CM. Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution. Stem Cells 2006; 24: 1121-1127
21. Pearson H. Stem-cell tagging shows flaws. Nature 2006; 439: 519